Value Adjusted for Debt and Cash: Cerevel Corp (CERE)
Cerevel Therapeutics (CERE) has completed its merger with a global pharma behemoth, focusing on integrating its developments into the buyer's structure. The business relies on creating advanced treatments for epilepsy and Parkinson's disease through the study of brain receptors. The price action on GURU.Markets, where the Enterprise Value is , confirms the brand's status as an authoritative developer of targeted therapies for schizophrenia.
Cerevel Therapeutics - analytical breakdowns and key metrics (CERE)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization information:
- business debt structure and liquidity details:
- earnings and market multiples details:
Analysis of all company metrics:Cerevel Therapeutics Inc
For Cerevel Therapeutics (CERE), which invests in elite talent and costly neurobiological research, the enterprise value reflects the total cost of a full business buyout inclusive of net debt. By analyzing the company's EV, an investor sees the real price of assets, which during periods of macroeconomic downturn can rapidly transform inflated expectations of scientific breakthroughs into substantial financial losses.
Competitors of Cerevel Therapeutics (CERE)
Biogen Inc (BIIB) - Total Enterprise Value|NBIX - Total Company Value|Value Adjusted for Debt and Cash RGC (Regencell Corp)|AXSM: Enterprise Value|Total Enterprise Value acadia-pharm.com (ACAD)|Total Company Value Xenon|Business Value VKTX (Viking Therapeutics Inc)|Enterprise Value SUPN|CPRX - Total Enterprise Value|Denali Therapeutics - Real Price to Acquire Entire Company|Enterprise Value harmonybiosciences.com HRMY|BHVN - Total Company Value|Value Adjusted for Debt and Cash AMLX (Amylyx Pharmaceuticals Inc)|Trevi Pharma (TRVI) - Total Company Value|Total Enterprise Value Praxis Corp (PRAX)|AVXL (Anavex Life Sciences) - Enterprise Value|Real Price to Acquire Entire Company ceribell.com (CBLL)|Enterprise Value PRTA|ALEC - Total Enterprise Value|Total Company Value Annexon Inc. ANNX|Value Adjusted for Debt and Cash OMER|Neurogene Inc. - Enterprise Value|Total Enterprise Value acimmune.com|VYGR (Voyager Therapeutics, Inc.) - Real Price to Acquire Entire Company|NMRA (Neumora) - Total Company Value|SCLX (Scilex Holding Co.) - Enterprise Value|Total Enterprise Value Tevogen Bio Inc. TVGN|Total Company Value Alpha Cognition (ACOG)|Total Company Value CGTX (Cognition Therapeutics Inc.)|Inhibikase Therapeutics, Inc. - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash SAVA|ASRT: Real Price to Acquire Entire Company|Coya Therapeutics, Inc. - Aggregate Business Value|VTGN: Enterprise Value|Ovid Therapeutics - Value Adjusted for Debt and Cash|ABOS (Acumen Pharmaceuticals, Inc.) - Enterprise Value|Total Enterprise Value CervoMed, Inc. CRVO|Total Company Value Alterity Therapeutics (ATHE)|CLNN (clene.com) - Value Adjusted for Debt and Cash|Enterprise Value PEPG (PepGen)|Enterprise Value Jupiter Neurosciences, Inc. JUNS|RLMD - Total Company Value|Full Business Value ANVS|GRCE: Enterprise Value|Total Enterprise Value Firefly Neuro (AIFF)|Real Price to Acquire Entire Company KLTO|Enterprise Value NeuroSense Therapeutics, Ltd.|Real Price to Acquire Entire Company RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Aggregate Business Value MTVA|Enterprise Value NRXS (NeurAxis, Inc)|Company Buyout Price Helius Medical Technologies, Inc. (HSDT)|Passage Bio Corp - Enterprise Value|Neuphoria Therapeutics Inc. (NEUP) - Real Price to Acquire Entire Company|Minerva Neurosciences, Inc. (NERV) - Total Company Value|ATHA - Company Buyout Price|ADXN (Addex Therapeutics, Ltd.) - Enterprise Value|Real Price to Acquire Entire Company Alzamend (ALZN)|Enterprise Value CYCN|PTIX - Total Enterprise Value|Total Company Value Pasithea Therapeutics Corp. KTTA|Value Adjusted for Debt and Cash CRGT|Avenue Therapeutics, Inc - Enterprise Value|Total Enterprise Value BrainStorm Cell Therapeutics Inc.|Cara Therapeutics, Inc. (CARA) - Total Company Value|Business Value CHRO|ELYM (Eliem Therapeutics, Inc.) - Enterprise Value|Total Enterprise Value Intra-Cellular ITCI|Real Price to Acquire Entire Company LBPH (Longboard Pharma)|Enterprise Value Marinus Pharma (MRNS)|Total Company Value NKGen Biotech, Inc. NKGN|Value Adjusted for Debt and Cash NRBO|SAGE - Total Company Value|Total Enterprise Value Synaptogenix Inc.|TRVN: Enterprise Value|Real Price to Acquire Entire Company Vigil Neuroscience, Inc.|WENA (Anew Medical) - Enterprise Value